NDC 49315-008 – Doxorubicin Hydrochloride
Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · Intravenous
Product NDC49315-008
Product details
- Brand name
- Doxorubicin Hydrochloride
- Generic name
- Doxorubicin hydrochloride
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- Injectable, Liposomal
- Route
- Intravenous
- Marketing category
- ANDA · ANDA212299
- Marketed since
- September 14, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anthracycline Topoisomerase Inhibitor
Active ingredients
- Doxorubicin Hydrochloride 2 mg/mL
Uses, dosage, side effects and warnings for Doxorubicin Hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 49315-008-03 | 1 VIAL, SINGLE-DOSE in 1 CARTON (49315-008-03) / 10 mL in 1 VIAL, SINGLE-DOSE | Sep 14, 2020 |
Other Doxorubicin Hydrochloride products
- 68001-704 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · BluePoint Laboratories
- 68001-345 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · BluePoint Laboratories
- 68001-703 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · BluePoint Laboratories
- 68001-492 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · BluePoint Laboratories
- 68001-493 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · BluePoint Laboratories
- 72603-103 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · NorthStar RxLLC
- 72603-200 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · NorthStar RxLLC
- 47335-050 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · Sun Pharmaceutical Industries, Inc.
- 47335-049 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · Sun Pharmaceutical Industries, Inc.
- 49315-009 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · Zydus Lifesciences Limited
- 70710-1531 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · Zydus Pharmaceuticals USA Inc.
- 70710-1530 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · Zydus Pharmaceuticals USA Inc.